LIVINGSTON, NJ— May 23, 2007— Robert S. Mills, president and chief executive officer of Columbia Laboratories, Inc. (NASDAQ: CBRX), will present at the upcoming Friedman, Billings, Ramsey & Co. Investor Growth Conference.
Date: Thursday, May 31, 2007
Time: 8:15 - 8:55 a.m. Eastern Time
Venue: The Grand Hyatt Hotel, New York City
Live webcast: www.cbrxir.com , under "Events"
This presentation will be archived for 90 days on Columbia Laboratories’ investor website, www.cbrxir.com , under "Events."
About Columbia Laboratories
Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company dedicated to the development and commercialization of women’s healthcare and endocrinology products that use its novel bioadhesive drug delivery technology. For more information, please visit www.columbialabs.com.
Contact: |
|
Investor and Media Contact: |
James A. Meer
Senior Vice President, CFO & Treasurer
(973) 486-8860 |
|
Melody A. Carey
Rx Communications Group, LLC
(917) 322-2571 |
